
Brena Lopes Miranda
Federal University of Piaui, BrazilTitle: The effect of COVID19
Abstract
The probiotic-rich diet helps in the
prevention and treatment of diseases, as well as in the balance of the
intestinal microbiota. This is a literature review that sought to assess the
effect of probiotics on the prevention and treatment of cancer and diabetes.
The electronic databases were: Scielo, LILACS, Virtual Health Library, Google
Scholar, Medline and Pubmed, articles in English, Spanish and Portuguese,
descriptors: Probiotics / Probiotics, Probiotics and diabetes / Probiotics and
diabetes and Probiotics and cancer / Probiotics and cancer; inclusion criteria:
full articles published in full, available in English, Spanish and Portuguese.
Initially found 12,000 articles with the descriptor probiotics, other
descriptors, the final result of 210 articles was obtained. It was observed
that cancer and diabetes are chronic diseases, considered by the World Health
Organization (WHO) as priority problems
of global public health, several studies have demonstrated beneficial actions
with the use of probiotics with in vivo and in vitro research, in the cancer,
probiotics reduce mutagenic and genotoxic effects, act with three host
protection mechanisms, in diabetes, probiotics can improve metabolic changes
such as insulin resistance, hyperglycemia, inflammation, dyslipidemia or NAFLD
in animals and act with beneficial mechanisms. The use of probiotics has a
beneficial role in the treatment of chronic non-communicable diseases such as
cancer and diabetes. In cancer, probiotic bacteria reduce mutagenic and genotoxic
effects, the benefits of probiotics in diabetes mellitus are the improvement in
metabolic changes associated with diabetes, such as insulin resistance,
hyperglycemia and inflammation.
Biography
Nutritionist at the Federal
University of Piauí - UFPI, Senator Helvídio Nunes de Barros Campus - CSHNB in
Picos - PI. Extensionist in the Mais Sorriso, Mais Saúde project. Ongoing
postgraduate degree in Nutrition with Emphasis on Obesity and Pediatrics -
FACIBA/FAVENI.